IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance.
NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius Capnography™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received CE marking ...
Masimo CO2, O3 and Sedline measurements are now available on Philips high acuity MX750 & MX850 IntelliVue monitors Philips patient monitors MX750 and MX850 in an operating room June 1, 2023 Amsterdam, ...
Masimo announced U.S. Food and Drug Administration 510(k) clearance for the Root patient monitoring and connectivity platform. The platform includes a built-in connectivity gateway through Iris for ...
Masimo (NASDAQ: MASI) announced the limited market release of Early Warning Score (EWS) on the Root ® patient monitoring and connectivity platform. EWS aggregates information from multiple vital signs ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ:MASI) announced today FDA clearance and U.S. release of the full family of NomoLine™ capnography sampling lines. NomoLine sampling lines are available ...
Masimo ($MASI) has gained FDA clearance for its wireless, wearable patient monitor, Radius-7. The device connects to Root, Masimo's open architecture, patient ...
Masimo Corporation MASI recently announced the findings of a prospective, single-blinded, randomized controlled study in which researchers sought to assess the impact of varying ventilation strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback